Dr Agarwals Eye Hospital informs about scheme of arrangement

17 Feb 2026 Evaluate
Dr Agarwals Eye Hospital has informed that this is with reference to letter dated August 27, 2025, intimating the approval of the Board of Directors of the Company to the Scheme, subject to receipt of applicable regulatory and other approvals. In this regard, they informed that the Company has received the observation letter conveying ‘no adverse observations’ from BSE on February 17, 2026, in relation to the Scheme. The Scheme remains subject to the receipt of necessary statutory and regulatory approvals as may be required under the applicable laws, including the approvals of the respective shareholders and creditors of the companies involved in the Scheme, and the jurisdictional National Company Law Tribunal. Copy of the aforesaid observation letter is enclosed and also made accessible on the Company’s website at https://dragarwals.co.in/dr-agarwals-eye-hospital/#scheme

The above information is a part of company’s filings submitted to BSE.

Dr Agarwals Eye Hsp Share Price

4754.10 -33.60 (-0.70%)
19-Feb-2026 15:03 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7595.30
Max Healthcare Inst 1081.95
Narayana Hrudayalay 1837.35
Aster DM Healthcare 635.05
Global Health 1142.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×